Developing the nation's biosimilars program
N Engl J Med
.
2011 Aug 4;365(5):385-8.
doi: 10.1056/NEJMp1107285.
Authors
Steven Kozlowski
1
,
Janet Woodcock
,
Karen Midthun
,
Rachel Behrman Sherman
Affiliation
1
U.S. Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
PMID:
21812668
DOI:
10.1056/NEJMp1107285
No abstract available
MeSH terms
Biological Products*
Government Regulation
Legislation, Drug*
Molecular Structure
Therapeutic Equivalency*
United States
United States Food and Drug Administration
Substances
Biological Products